Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Netarsudil dose-ranging study in open-angle glaucoma or ocular hypertension (Japan)
jRCT2080224561Phase 2Completed
- Sponsor
- Aerie Pharmaceuticals
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of netarsudil in open-angle glaucoma (OAG) and ocular hypertension (3 arms), sponsored by Aerie Pharmaceuticals. Started Feb 2019; status: completed.
02
Drugs
netarsudil
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on jRCT2080224561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224561.